Diagnostic accuracy of early biomarkers for acute coronary syndrome (ACS) (2012)
poster
posted on 2020-04-22, 11:40 authored by Christopher CarrollChristopher Carroll, Stephen GoodacreStephen Goodacre, John Stevens, Joanna LeavissJoanna LeavissBackground: Current practice for suspected ACS involves troponin testing 10-12 hours after symptom onset to diagnose myocardial infarction (MI).
Aim: To estimate the diagnostic accuracy of early biomarkers
for MI to determine if an earlier, accurate decision was possible
Rationale: Early discharge of patients with no or low risk of ACS will result in cost savings and reduced healthcare and patient burden.
History
Ethics
There is no personal data or any that requires ethical approvalPolicy
The data complies with the institution and funders' policies on access and sharingSharing and access restrictions
The data can be shared openlyData description
- The file formats are open or commonly used
Methodology, headings and units
- Headings and units are explained in the files
CC BY 4.0